PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 14 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Fruit extracts stimulated the growth of young human chondrocytes [PMID:28906146].
Methanol extract of the stem was investigated for anti-diabetic activity in STZ-induced HFD type 2 diabetes mellitus rat models [PMID:40581171].
Methanol leaf extract demonstrated anti-inflammatory and antibacterial potential against pathogens including E. coli and K. pneumoniae [PMID:41831095].
Recombinant Caryota mitis profilin (rCmP)-loaded PLGA nanoparticles showed immunotherapeutic effects in a murine model [PMID:24376349].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 40436126 (2025) — Ethnopharmacological and scientific validation of Caryota mitis Lour fruit peel for osteoarthritis and gout management. · Journal of ethnopharmacology
- 2.PMID: 40581171 (2025) — Exploring anti-diabetic activity of Caryota mitis Lour. through modulation of PPAR- α/γ, GLUT-4, using in-vitro, in-vivo and in-silico approaches. · Journal of ethnopharmacology
- 3.PMID: 33559930 (2021) — Comparative metabolites profiling of Caryota mitis & Caryota urens via UPLC/MS and isolation of two novel in silico chemopreventive flavonoids. · Journal of food biochemistry
- 4.PMID: 24376349 (2013) — Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma. · International journal of nanomedicine
- 5.PMID: 473178